Pollen Immunotherapy for Children: When It Helps

For some children, hay fever is far more than a few sneezes in the park. A blocked nose can disrupt sleep, concentration and sport; itchy eyes can make school days miserable; and pollen season may worsen asthma symptoms. Pollen immunotherapy for children may be considered when these problems remain significant despite well-planned standard treatment. It is a specialist treatment, not a quick seasonal remedy, and careful assessment matters.

What is pollen immunotherapy?

Immunotherapy aims to change the way a child’s immune system responds to a specific allergen. Rather than simply relieving symptoms once they appear, it involves giving controlled, regular doses of the relevant pollen allergen over a prolonged period. The intention is to build tolerance gradually, reducing symptoms and the need for medication over future pollen seasons.

For children with genuine, persistent pollen-driven allergic rhinitis, this can be a valuable option. However, it will not suit every child with hay fever. A child may react to grass pollen, tree pollen, mould spores, house dust mite or several triggers at once. Their symptoms may also be caused partly by non-allergic rhinitis, recurrent viral infections or enlarged adenoids. Immunotherapy is most useful when there is a clear match between the child’s history, their pattern of symptoms and evidence of sensitisation to the pollen being treated.

The treatment is usually considered for moderate to severe allergic rhinitis, particularly when symptoms interfere substantially with daily life despite using medicines correctly. It can also be relevant for children whose pollen allergy contributes to asthma symptoms, although asthma must be carefully assessed and well controlled before treatment begins.

Why ordinary hay fever treatment should come first

Many children are referred for specialist help having tried an antihistamine occasionally, often only after symptoms are already severe. Before considering immunotherapy, it is worth checking whether standard treatment has been given the best possible chance to work.

For most children, an effective hay fever plan may include a non-sedating antihistamine, a steroid nasal spray used regularly and with the correct technique, and eye drops where needed. Starting treatment before the expected pollen season can make a real difference. Practical measures also help: showering and changing clothes after being outdoors, keeping bedroom windows closed when pollen counts are high, and drying laundry indoors where possible.

If a child remains very symptomatic despite this approach, a paediatric allergy assessment can clarify whether pollen immunotherapy is likely to offer worthwhile benefit. This avoids committing a family to a lengthy treatment course when another explanation or a simpler adjustment to treatment may be more appropriate.

Assessment before pollen immunotherapy for children

A specialist assessment begins with the story behind the symptoms. The timing is especially useful. Grass pollen symptoms often peak from late spring into summer, while tree pollen can cause problems earlier in the year. A symptom diary can help identify whether symptoms reliably follow this pattern or continue throughout the year.

The consultation should also explore eczema, food allergy, asthma, recurrent wheeze and any previous serious allergic reactions. Asthma deserves particular attention because uncontrolled asthma increases the risk associated with allergen immunotherapy.

Skin prick testing and specific IgE blood tests may be used to look for sensitisation to relevant pollens. These tests are helpful, but they do not diagnose a clinical allergy on their own. A positive result means the immune system recognises an allergen; it does not prove that it is responsible for a child’s symptoms. Specialist interpretation is essential, especially when several test results are positive.

Families should expect a discussion about the practical commitment as well as the medical suitability. Immunotherapy commonly runs for around three years. It works best when doses are taken or attended consistently, so school routines, holidays, transport and a child’s willingness to engage all need to be considered.

How treatment is given

Pollen immunotherapy is generally delivered either under the tongue or by injection. The most suitable route depends on the pollen involved, the child’s age, the available licensed treatment, local arrangements and clinical judgement.

Sublingual immunotherapy

Sublingual immunotherapy involves placing a tablet, or in some circumstances an allergen preparation, under the tongue. The first dose is usually given under medical supervision, with an observation period afterwards. Subsequent doses are taken at home exactly as prescribed.

This approach avoids frequent injections, which can make it more acceptable for many children. The trade-off is that daily adherence is essential. Parents and teenagers need to be confident that doses will not be repeatedly missed, particularly during busy school weeks or when away from home.

Mild itching or tingling in the mouth and throat can occur at the start of treatment and often settles. A specialist team will explain what is expected, what to do if a dose is missed or the child is unwell, and which symptoms require urgent advice.

Subcutaneous immunotherapy

Subcutaneous immunotherapy is given by injection in a clinical setting. It usually involves an initial build-up phase followed by maintenance injections at regular intervals. Children remain under observation after each injection because allergic reactions, while uncommon in a properly selected and supervised patient, can occur.

This method provides regular clinical contact and does not rely on a daily home dose. On the other hand, it requires repeated appointments and can be disruptive for school and family schedules. For some children, the prospect of injections is also a significant barrier.

Not every pollen allergen has the same treatment options, and product licences and age criteria differ. A recommendation should therefore be based on the individual child rather than a promise that one route is always better.

Safety and the questions parents should ask

A structured safety plan is central to immunotherapy. Before starting, parents should understand when treatment should be delayed, such as during an asthma flare, significant breathing symptoms, a feverish illness or following certain dental procedures for some under-the-tongue treatments. They should also know how to contact the clinical team if concerns arise.

The child’s current medicines and health conditions need review, including asthma inhalers. If asthma is present, families should have a clear action plan and should report cough, wheeze, night waking or reduced exercise tolerance promptly. Immunotherapy should not be used as a substitute for good asthma care.

It is reasonable to ask what improvement is realistic. Some children experience a clear reduction in nasal, eye and asthma-related symptoms and need less rescue medication. Others improve more modestly. Benefit is usually assessed over seasons, not days or weeks, and standard hay fever treatment may still be needed during the course.

Parents should also ask whether the proposed treatment is licensed for their child’s age and allergen, how progress will be reviewed, what happens if doses are missed, and whether school needs written guidance. A school may need to know about prescribed medicines and the plan for managing symptoms, especially if the child takes doses before leaving home or attends regular clinic appointments.

When immunotherapy may not be the right next step

Immunotherapy may not be suitable where symptoms are mild, where the trigger is uncertain, or where medication technique and adherence have not yet been optimised. It may also be deferred if asthma is not well controlled or if a family cannot realistically commit to the treatment schedule.

There are situations where the right answer is further investigation rather than immunotherapy. Persistent nasal blockage outside pollen season, frequent snoring, facial pain, repeated sinus symptoms or poor response to treatment may warrant assessment for other causes. Similarly, a child with troublesome symptoms at home all year may have house dust mite or pet allergy rather than a pollen problem alone.

A consultant-led paediatric allergy assessment can help separate these possibilities and create a plan that makes sense for the child’s daily life. At Children’s Allergy Cambridge, this means looking beyond the test result to the child’s symptoms, asthma status, school routine and family priorities before discussing appropriate treatment pathways.

Making the decision as a family

Choosing immunotherapy is not about finding a cure before the next sunny weekend. It is a considered decision to invest time and consistency in reducing the burden of allergy over the longer term. For the right child, that may mean more comfortable sleep, better concentration in class and more freedom to enjoy being outdoors in pollen season.

The most useful next step is a careful conversation with a paediatric allergy specialist, bringing details of symptom timing, current medicines, asthma history and any previous test results. A clear diagnosis and a realistic plan can give families something more valuable than guesswork: confidence about what their child needs now, and what may help in the seasons ahead.